Back | Next |
home / stock / tlsa / tlsa message board
Subject | By | Source | When |
---|---|---|---|
$TLSA MomentumIts gaining | The Night Stalker | investorshub | 09/26/2023 6:29:22 AM |
The gaining | Anita Dump | investorshub | 09/26/2023 4:39:55 AM |
bears and bulls | Ryguy008 | investorshub | 09/26/2023 4:38:39 AM |
Thoughts on where this is headed? | The Night Stalker | investorshub | 09/26/2023 4:31:09 AM |
Price trading last up | The Night Stalker | investorshub | 09/26/2023 12:29:30 AM |
$TLSA Price gaining | The Night Stalker | investorshub | 09/25/2023 11:40:58 PM |
MomentumIts trading last up | mfayman | investorshub | 09/25/2023 10:38:10 PM |
Good read | EOT | investorshub | 09/25/2023 1:41:41 PM |
$TLSA Do we have a winner?Turn around time? | Crusader | investorshub | 09/25/2023 11:32:02 AM |
$TLSA The gaining last up | ElvisCobain | investorshub | 09/25/2023 10:21:47 AM |
$TLSA news all the way baby | The Night Stalker | investorshub | 09/25/2023 10:15:27 AM |
$TLSA Time for this to show some returns | Anita Dump | investorshub | 09/25/2023 8:56:20 AM |
The now last up | Anita Dump | investorshub | 09/25/2023 8:12:56 AM |
$TLSA Price gaining last up | Count Crypto | investorshub | 09/25/2023 7:44:34 AM |
$TLSA Price gaining | The Night Stalker | investorshub | 09/25/2023 5:55:30 AM |
$TLSA must see | Ryguy008 | investorshub | 09/25/2023 5:37:43 AM |
$TLSA bulls and bears | Count Crypto | investorshub | 09/25/2023 3:38:21 AM |
$TLSA Looks pretty positive | nickwill69 | investorshub | 09/25/2023 12:04:53 AM |
$TLSA news all the way baby | Count Crypto | investorshub | 09/24/2023 10:59:54 PM |
Price now up | Anita Dump | investorshub | 09/24/2023 10:11:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Tiziana Life Sciences plc Company Name:
TLSA Stock Symbol:
NASDAQ Market:
Tiziana Life Sciences plc Website:
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, ant...
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough therapies in neurodegenerative disease secondary to active neuroinflammatory processes today announced t...
--News Direct-- Tiziana Life Sciences Ltd (NASDAQ:TLSA) chairman and CEO Gabriele Cerrone joined Proactive's Stephen Gunnion with more details of the company's recent advancements and news. Tiziana Life Sciences is developing a fully human CD3 monoclonal antibody, delivered intranasally, ...